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•OH

:   hydroxyl radical

ALOX

:   lipoxygenase

COX

:   cyclooxygenase

DOPC

:   1,2‐dioleoyl‐sn‐glycero‐3‐phosphocholine

H~2~O~2~

:   hydrogen peroxide

HNE

:   4‐Hydroxynonenal

HPF

:   Hydroxyphenyl fluorescein

MIC

:   microscope observation

NDGA

:   nordihydroguaiaretic acid

PINK1

:   PTEN‐induced kinase 1

POVPC

:   1‐palmitoyl‐2‐(5′‐oxo‐valeroyl)‐sn‐glycero‐3‐phosphocholine

ROS

:   Reactive oxygen species

RT

:   radiation therapy

1. INTRODUCTION {#cas14132-sec-0001}
===============

ROS are defined as chemically reactive species containing oxygen, some of which are peroxidases or hydroxyl radicals. ROS production is effective in the chemotherapy and RT of cancer.[1](#cas14132-bib-0001){ref-type="ref"}, [2](#cas14132-bib-0002){ref-type="ref"}, [3](#cas14132-bib-0003){ref-type="ref"} Numerous chemicals can produce ROS than affect cancer cells[4](#cas14132-bib-0004){ref-type="ref"}, [5](#cas14132-bib-0005){ref-type="ref"}, [6](#cas14132-bib-0006){ref-type="ref"}, [7](#cas14132-bib-0007){ref-type="ref"}, [8](#cas14132-bib-0008){ref-type="ref"} and some of these are under investigation in clinical trials.[9](#cas14132-bib-0009){ref-type="ref"} Some ROS, for example H~2~O~2~, are used as sensitizers of cancer cells by producing reactive oxygen during RT.[10](#cas14132-bib-0010){ref-type="ref"}, [11](#cas14132-bib-0011){ref-type="ref"} Similarly, ROS are produced by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in the cytoplasm.[12](#cas14132-bib-0012){ref-type="ref"} However, the main source of ROS may be the mitochondrial electron transport chain through oxidative phosphorylation.[13](#cas14132-bib-0013){ref-type="ref"}, [14](#cas14132-bib-0014){ref-type="ref"} Mitochondrial DNA (mtDNA) encodes 13 proteins that are components of the mitochondrial electron transport chain. Damage to mtDNA results in increased production of ROS, conversely causing neurodegenerative diseases and various types of cancer.[15](#cas14132-bib-0015){ref-type="ref"}, [16](#cas14132-bib-0016){ref-type="ref"} Therefore, these mtDNA‐damaged cells may be valuable models for studying ROS‐related disease. Mitochondrial DNA devoid ρ^0^ cells were established from a human cervical cancer cell line (HeLa) and from an oral squamous cell carcinoma (SAS). These ρ^0^ cells were sensitive to ROS, in particular H~2~O~2~.[17](#cas14132-bib-0017){ref-type="ref"} Notably, yeast ρ^0^ cells have also shown sensitivity to treatment with H~2~O~2~.[18](#cas14132-bib-0018){ref-type="ref"} Recently, ρ^0^ cells from osteosarcoma and lung carcinoma have shown sensitivity to X‐ray irradiation related to oxidative stress.[19](#cas14132-bib-0019){ref-type="ref"} Conversely, there are several studies reporting that ρ^0^ cells are resistant to oxidative stress, especially to radiation. ρ^0^ cells from human fibroblasts have shown resistance to γ‐irradiation by decreasing apoptosis.[20](#cas14132-bib-0020){ref-type="ref"} In addition, ρ^0^ cells from the human pancreatic tumor MiaPaCa‐2 cell line showed resistance to X‐ray irradiation via activation of cyclin B1.[21](#cas14132-bib-0021){ref-type="ref"} Moreover, ρ^0^ cells from healthy human bronchial epithelial cells have shown resistance to oxidative stress. At present, the sensitivity or resistance of ρ^0^ cells to oxidative stress and the stress response mechanism involved in these processes have not been fully elucidated.

ROS react with polyunsaturated fatty acids in the lipid membranes, inducing lipid peroxidation that leads to cell death. HNE, the end product of lipid peroxidation reacts with low‐molecular‐weight compounds (eg, glutathione, proteins, and DNA), and is considered a second messenger of oxidative stress.[22](#cas14132-bib-0022){ref-type="ref"}, [23](#cas14132-bib-0023){ref-type="ref"} Notably, HNE production occurs through the ROS generation and an enzymatic process.[24](#cas14132-bib-0024){ref-type="ref"} The key enzyme in the production of HNE is ALOX15. The relationship between the level of HNE and ALOX15 has been previously reported.[25](#cas14132-bib-0025){ref-type="ref"} It has also been reported HNE induces expression of the *COX2* gene.[26](#cas14132-bib-0026){ref-type="ref"} However, so far, the relationship between ρ^0^ cells and ALOXs and/or COX2 has not been investigated.

Moreover, the mechanism of sensitivity to H~2~O~2~ in ρ^0^ cells via oxidation of the plasma membrane has not been elucidated. In this study, we investigated the oxidation state of the plasma membrane in ρ^0^ cells, and identified factors that control this process.

2. MATERIALS AND METHODS {#cas14132-sec-0002}
========================

2.1. Cell culture {#cas14132-sec-0003}
-----------------

Human cancer cell lines HeLa and SAS were obtained from the Cell Resource Center for Biomedical Research, Institute of Development, Aging and Cancer, Tohoku University (Sendai, Japan). ρ^0^ cells were established through culture in RPMI1640 (Wako Pure Chemical Industries Ltd., Osaka, Japan) containing 5% FBS (Gibco Invitrogen Corp., Carlsbad, CA, USA), 50 ng/mL ethidium bromide (Nacalai Tesque Inc., Kyoto, Japan), 50 μg/mL uridine (Sigma‐Aldrich, St Louis, MO, USA), and 110 μg/mL sodium pyruvate (Sigma‐Aldrich) for 3‐4 wk.[17](#cas14132-bib-0017){ref-type="ref"} Cells were maintained in RPMI 1640 supplemented with 10% FBS, 50 μg/mL uridine, and 110 μg/mL sodium pyruvate in a humidified atmosphere at 37°C with 5% carbon dioxide. Exponentially growing cells were used in all experiments.

2.2. Relative levels of internal H~2~O~2~ {#cas14132-sec-0004}
-----------------------------------------

Internal H~2~O~2~ was visualized using HYDROP™ (Goryo Chemical Inc., Hokkaido, Japan) as previously described.[17](#cas14132-bib-0017){ref-type="ref"} Briefly, cells in glass‐bottomed dishes (Matsunami Glass Ind., Ltd., Osaka, Japan) were cultured in RPMI 1640 with or without 50 μmol/L H~2~O~2~ for 10 min, 30 min, 1 h, and 2 h. The cultured cells were washed with noncontaining H~2~O~2~ RPMI 1640 twice to remove the H~2~O~2~ from the medium, and subjected to treatment with 2.5 μmol/L HYDROP™ in RPMI 1640 at 37ºC for 20 min. Subsequently, the cells were washed with RPMI 1640 twice, and fluorescence images were obtained using a BZ‐8000 fluorescence microscope (Keyence Corporation, Osaka, Japan). The ImageJ software (Rasband, W.S., ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA, <http://rsb.info.nih.gov/ij/>, 1997‐2012) was used to measure fluorescence intensity.

2.3. Intracellular intake of H~2~O~2~ using a stable isotope {#cas14132-sec-0005}
------------------------------------------------------------

A H~2~O~2~ ^18^O~2~ solution (Sigma‐Aldrich) was used to measure the intracellular intake of H~2~O~2~. Cells were subjected to treatment with 50 μmol/L H~2~O~2~ ^18^O~2~ solution for 1 h. After treatment, the cells were washed with phosphate‐buffered saline (PBS) three times. Following the wash, the cells were collected and dried using an FDU‐2200 freeze dryer (Tokyo Rikakikai Co. Ltd., Tokyo, Japan) for 3 h. Dried samples were sent for analysis to Taiyo Nippon Sanso Corporation (Tokyo, Japan). The levels of ^18^O~2~ in treated cells were measured using stable isotope‐ratio mass spectrometry. The results are shown as delta ‰ compared with the standard mean ocean water (^18O^δ SMOW ‰).

2.4. Immunofluorescence {#cas14132-sec-0006}
-----------------------

Cells were cultured in glass‐bottomed dishes using RPMI 1640 with or without 50 μmol/L H~2~O~2~ for 1 and 2 h. Subsequently, the cells were fixed with 4% formaldehyde in PBS for 30 min, and rinsed three times with PBS. Plasma membranes were permeabilized by incubation in 95% ethanol with 5% acetic acid for 10 min. After washing five times with PBS, cells were incubated for 30 min in blocking solution (5% skimmed milk in PBS‐T; PBS with 0.05% Tween 20). The primary antibodies (incubated at 4°C overnight) were mouse anti‐HNE (1:200 dilution; Japan institute for the control of aging, Shizuoka, Japan), rabbit anti‐PINK1, anti‐aquaporin11, anti‐ALOX5, anti‐ALOX12, and anti‐ALOX15 antibodies (Novus Biologicals, Centennial, CO, USA: BC100‐494; ABGENT San Diego, CA, USA: AP58056; Abcam, Cambridge, UK: ab169755, ab211506, and ab80221; 1:1000 dilution), mouse anti‐COX1 (Abcam: ab695; 1:500 dilution), and rabbit anti‐COX2 (Abcam: ab15191; 1:100 dilution). The secondary antibodies (1:200 dilution, incubated at room temperature for 1 h) were the Alexa Fluor 488 goat anti‐mouse IgG and Alexa Fluor 568 goat anti‐rabbit IgG (Thermo Fisher Scientific, Waltham, MA, USA: A11001, and A11011). For staining the nuclei, cells were incubated with DAPI (0.5 μg/mL) at room temperature for 10 min. A BZ‐8000 fluorescence microscope was used to obtain fluorescence images, and the ImageJ software was used to measure fluorescence intensity.

2.5. Liposome assay {#cas14132-sec-0007}
-------------------

Liposomes containing luminol and horseradish peroxidase (HRP) were prepared as follows: DOPC (Avanti Polar Lipids Inc., Albaster, AL, USA) and POVPC (Avanti Polar Lipids Inc.) were dissolved in chloroform (1 mg/mL) and mixed together. The dissolved lipids were dried to remove the chloroform. Subsequently, the mixture was added to 50 mmol/L Tris‐HCl (pH 8.6) buffer containing 10 mmol/L luminol (Nacalai Tesque Inc.: 20751‐34) and 100 μmol/L HRP (Wako Pure Chemical Industries Ltd.: 169‐10791) and was then sonicated The diameter of the prepared liposomes was calculated via the Dynamic Light Scattering method using ELS‐Z2M (Otsuka Electronics Co. Ltd., Osaka, Japan). Subsequently, 8.8 mmol/L H~2~O~2~ were administered to the liposomes, and luminescence was observed using a luminometer (JASCO, Tokyo, Japan: FP‐6300). Passage of H~2~O~2~ through the liposome membrane resulted in luminol reaction, producing blue luminescence.

2.6. Administration of oxidized lipid {#cas14132-sec-0008}
-------------------------------------

POVPC (12.5‐50 μmol/L) was administered to the cultured medium using the ethanol injection method.[27](#cas14132-bib-0027){ref-type="ref"}, [28](#cas14132-bib-0028){ref-type="ref"} This lipid has been shown to localize to the plasma membrane.[27](#cas14132-bib-0027){ref-type="ref"}, [28](#cas14132-bib-0028){ref-type="ref"} After 10 min (SAS) or 30 min (HeLa) of treatment, POVPC was removed, and the cells were treated with 25 μmol/L H~2~O~2~ for 48 h. After administration of POVPC and H~2~O~2~, cell survival was analyzed using the CCK‐8 assay kit (Dojindo Molecular Technologies, Inc., Kumamoto, Japan), as previously described.[17](#cas14132-bib-0017){ref-type="ref"}

2.7. Quantitative PCR {#cas14132-sec-0009}
---------------------

Total RNA was extracted using ISOGEN (Nippon Gene, Toyama, Japan), and reverse transcription was performed as previously described.[17](#cas14132-bib-0017){ref-type="ref"} cDNA equivalent to 1 ng of total RNA was used for the Quantitative PCR (qPCR). The reactions were performed with Step One Plus (Applied Biosystems; Foster City, CA, USA) using THUNDERBIRD^®^ qPCR Mix (TOYOBO, Osaka, Japan). β*‐actin* was used as the loading control. For the amplification of genes, one cycle of denaturation (95°C for 10 min) was performed, followed by 40 cycles of amplification (95°C for 10 s and 60°C for 60 s). Each experiment was performed in triplicate. Table [1](#cas14132-tbl-0001){ref-type="table"} lists the primer sequences used in this experiment.

###### 

Primer sequences

  Primer name   Primer sequence
  ------------- --------------------------------------
  *ALOX5* F     5′‐CTGGGCATGTACCCAGAAGAGCATTTTAT‐3′
  *ALOX5* R     5′‐ACAAGTAGTAATATGGCAGCTGCTTCTTCT‐3′
  *ALOX12* F    5′‐TTCAAATGGCCATCTCATGGCATCTGAGT‐3′
  *ALOX12* R    5′‐ATCTGTTCGGAATTGGTTTAGCACAGCTTT‐3′
  *ALOX15* F    5′‐ATCTATCGGTATGTGGAAGGAATCGTGAGT‐3′
  *ALOX15* R    5′‐TAAAGAGACAGGAAACCCTCGGTCCT‐3′
  *COX1* F      5′‐AATCCCATCTGTTCTCCGGAGTACTG‐3′
  *COX1* R      5′‐GAAACGTAGGGACAGGTCTTGGTGTT‐3′
  *COX2* F      5′‐TGGAGCACCATTCTCCTTGAAAGGACTTAT‐3′
  *COX2* R      5′‐GACTGTTTTAATGAGCTCTGGATCTGGAAC‐3′
  β*‐Actin* F   5′‐AGAGCTACGAGCTGCCTGAC‐3′
  β*‐Actin* R   5′‐AGCACTGTGTTGGCGTACAG‐3′

John Wiley & Sons, Ltd

2.8. Western blotting {#cas14132-sec-0010}
---------------------

Each cell lysate (30 μg per lane) was subjected to SDS‐PAGE under reduced conditions using a 10% or 15% polyacrylamide gel. The proteins were subsequently blotted on a PVDF membrane. After blocking with blocking buffer (3% skimmed milk in TBS‐T; TBS with 0.05% Tween 20, for ALOX12 antibody and 5% skimmed milk in PBS‐T for the other primary antibodies), the blotted membranes were incubated with primary antibodies (rabbit anti‐ALOX5, anti‐ALOX12, anti‐ALOX15, mouse anti‐COX1, rabbit anti‐COX2; Abcam: ab169755, ab211506, ab80221, ab695, and ab15191, rabbit anti‐Akt, pAkt^T308^, pAkt^S473^, FOXO1, pGSK3β^S9^: Cell Signaling Technology, Danvers, MA, USA: \#4691, \#13038, \#4060, \#2880, \#5558, mouse anti‐BCL2, Bax; Santa Cruz Biotechnology, San Diego, CA, USA: SC‐7382, SC‐7480) in blocking buffer at 4ºC overnight. After five washes with TBS‐T (ALOX12 antibody) or PBS‐T (other antibodies), the membranes were incubated with peroxidase‐conjugated anti‐rabbit IgG antibody or anti‐mouse IgG antibodies (GE Healthcare UK Ltd., Amersham Place, England) at room temperature for 2 h. Immunoreactive proteins were visualized with ECL prime (GE Healthcare) using ChemiDoc XRS Plus (BIO‐RAD Laboratories, Inc., Hercules, CA, USA). An anti‐β‐actin antibody (Novus Biologicals LLC, Centennial, CO, USA; NB100‐56874) was used as loading control. The dilution factor for all antibodies was 1:1000. Table [2](#cas14132-tbl-0002){ref-type="table"} represents the mean and standard error of the mean (SEM*)* of three independent ρ^0^/parent intensity ratios after normalization against β‐actin.

###### 

Relative levels of protein expression in HeLa and SAS ρ^0^/parent cells (n = 3)

               ρ^0^/parent   SEM
  ------------ ------------- -----
  ALOX5                      
  HeLa         0.61          .16
  SAS          0.61          .01
  ALOX12                     
  HeLa         1.51          .14
  SAS          1.24          .05
  ALOX15                     
  HeLa         1.42          .04
  SAS          1.24          .05
  COX1                       
  HeLa         1.14          .01
  SAS          1.08          .05
  COX2                       
  HeLa         0.53          .14
  SAS          0.36          .05
  Akt                        
  HeLa         0.87          .07
  SAS          1.00          .01
  pAkt^T308^                 
  HeLa         0.64          .13
  SAS          0.49          .20
  pAkt^S473^                 
  HeLa         0.52          .17
  SAS          0.63          .14
  FOXO1                      
  HeLa         1.44          .17
  SAS          1.28          .07
  GSK3β^S9^                  
  HeLa         0.71          .11
  SAS          0.72          .16
  BCL2                       
  HeLa         0.78          .00
  SAS          0.67          .11
  Bax                        
  HeLa         1.88          .04
  SAS          1.31          .01

John Wiley & Sons, Ltd

2.9. ALOX inhibitor assay {#cas14132-sec-0011}
-------------------------

Cells were treated with 10 μmol/L caffeic acid (Nacalai Tesque Inc.), the ALOX5 inhibitor, or 10 μmol/L NDGA (Sigma‐Aldrich), the nonspecific ALOXs inhibitor, at 37ºC for 10 min. After removal of the inhibitor‐containing medium, the cells were treated with 50 μmol/L H~2~O~2~ for 1 h. HYDROP™ and HNE antibody were used as described above to detect internal H~2~O~2~ or HNE.

2.10. Detection of OH using HPF {#cas14132-sec-0012}
-------------------------------

Internal levels of ･OH were detected using HPF (Goryo Chemical Inc.) according to the protocol provided by the manufacturer with slight modification. HPF (10 μmol/L) with MIC buffer (130 mmol/L sodium chloride, 5.3 mmol/L potassium chloride, 0.8 mmol/L magnesium sulfate, 1 mmol/L disodium phosphate, 2 mmol/L glucose, 20 mmol/L HEPES, 1 mmol/L sodium pyruvate, 2.5 mmol/L sodium bicarbonate, 1 mmol/L ascorbic acid, 1.5 mmol/L calcium chloride, and 1.5 mg/mL bovine serum albumin (BSA)) was added to the cells in glass‐bottomed dishes. After incubation at 37°C for 15 min, the HPF with MIC buffer was replaced with new MIC buffer. Images were obtained using a BZ‐8000 fluorescence microscope. Nuclei were counterstained with DAPI as described above.

2.11. Statistical analysis {#cas14132-sec-0013}
--------------------------

One‐way analysis of variance with Scheffe\'s F test was performed for the water‐soluble tetrazolium assay and ALOX inhibitor experiment. All other statistical analyses were performed using Student\'s *t* test. A *P *\<* *.05 denoted statistical significance. The results were expressed as means ± SEM.

3. RESULTS {#cas14132-sec-0014}
==========

3.1. Relative levels of internal H~2~O~2~ and intake of H~2~O~2~ {#cas14132-sec-0015}
----------------------------------------------------------------

After treatment for 1 h, the internal levels of H~2~O~2~ were increased only in ρ^0^ vs parental cells (Figure [1](#cas14132-fig-0001){ref-type="fig"}A). The results obtained from the treatment with ^18^O~2~‐labeled H~2~O~2~ showed that the intake of H~2~O~2~ in ρ^0^ cells was significantly higher than that observed in parental cells after treatment with H~2~O~2~ for 1 h (Figure [1](#cas14132-fig-0001){ref-type="fig"}B).

![Internal levels of H~2~O~2~ and intracellular intake of H~2~O~2~ in ρ^0^ cells. A, Temporal change of H~2~O~2~ after treatment with H~2~O~2~ in ρ^0^ and parental cells using HYDROP™. In ρ^0^ cells, the relative H~2~O~2~ intensity was increased after treatment with H~2~O~2~ for 1 h. B, The intracellular intake of H~2~O~2~ was detected using a stable isotope~.~ Cells were subjected to 50 μmol/L of H~2~O~2~ ^18^O~2~ solution, and the content of ^18^O~2~ was measured using stable isotope‐ratio mass spectrometry. In ρ^0^ cells, the intake of H~2~O~2~ was significantly higher than that observed in parental cells after treatment. The results are expressed as the mean ± SEM. \*\**P *\<* *.01 using Student\'s *t* test](CAS-110-2856-g001){#cas14132-fig-0001}

3.2. Timing of increase in lipid peroxidation and internal levels of H~2~O~2~ {#cas14132-sec-0016}
-----------------------------------------------------------------------------

Significantly higher intensity was observed in ρ^0^ cells (Figure [2](#cas14132-fig-0002){ref-type="fig"}A, B). Co‐staining with PINK1 (localized in mitochondria) and aquaporin 11 (localized in the plasma membrane) revealed that HNE was mainly localized in the plasma membrane (Figure [2](#cas14132-fig-0002){ref-type="fig"}C, D). Moreover, temporal change of lipid peroxidation was observed to investigate the timing of this process after treatment with H~2~O~2~ (Figure [2](#cas14132-fig-0002){ref-type="fig"}E). Lipid peroxidation was increased 1 h after treatment (Figure [2](#cas14132-fig-0002){ref-type="fig"}E, F), whereas the internal levels of H~2~O~2~ were increased in parental cells 2 h after treatment (Figure [2](#cas14132-fig-0002){ref-type="fig"}F).

![Timing of increase in lipid peroxidation and internal H~2~O~2~ levels. A, Immunofluorescence images of 4‐hydroxynonenal (HNE). B, Relative HNE intensity. (C, D) HNE staining with PINK1 (localized in the mitochondria, C) and AQP11 (localized in the plasma membrane, D). HNE was mainly co‐localized with AQP11 that is present in the plasma membrane. E, Immunofluorescence images of HNE in HeLa and SAS parental cells after treatment with H~2~O~2~. F, Timing of lipid peroxidation and internal H~2~O~2~ levels. The results are expressed as the mean ± SEM. \*\**P *\<* *.01 using Student\'s *t* test](CAS-110-2856-g002){#cas14132-fig-0002}

3.3. H~2~O~2~ permeability using liposome and administration of oxidized lipid {#cas14132-sec-0017}
------------------------------------------------------------------------------

We prepared liposomes encapsulating luminol and HRP to quantify the permeation of H~2~O~2~. Representative phospholipids of the plasma membrane (ie, DOPC and oxidized lipid POVPC) were used in this model. Internal levels of H~2~O~2~ can be detected as luminescence of luminol catalyzed by HRP (Figure [3](#cas14132-fig-0003){ref-type="fig"}A). The intensity of luminescence was increased following the administration of H~2~O~2~. Differential DOPC/POVPC ratio liposomes were prepared to investigate changes in H~2~O~2~ permeability. Maximum H~2~O~2~ transport appeared in the presence of several (2‐4) mol% of POVPC (Figure [3](#cas14132-fig-0003){ref-type="fig"}B). The POVPC administration experiment was conducted to confirm whether administration of this oxidized lipid led to cell death. The results showed that the administration of 12.5 μmol/L POVPC significantly increased the sensitivity of HeLa and SAS parental cells to H~2~O~2~. However, a higher concentration of POVPC did not induce a similar increase in sensitivity to H~2~O~2~ (Figure [3](#cas14132-fig-0003){ref-type="fig"}C). Furthermore, administration of different concentrations of POVPC revealed that the relationship between cell viability and POVPC concentration did not show a linear concentration‐dependent pattern. However, it showed a reverse bell shape, with the lowest viability in HeLa and SAS parental cells observed after the administration of 12.5 μmol/L POVPC (Figure [3](#cas14132-fig-0003){ref-type="fig"}D). In contrast, administration of 12.5 μmol/L POVPC did not increase sensitivity to H~2~O~2~. The relationship between cell viability and the concentration of POVPC showed a linear concentration‐dependent pattern in HeLa and SAS ρ^0^ cells that contained more oxidized lipid before treatment (Figure [3](#cas14132-fig-0003){ref-type="fig"}E, F).

![H~2~O~2~ permeability using liposome and administration of oxidized lipid. A, Structure of the liposome. The representative phospholipids of the plasma membrane (ie, 1,2‐dioleoyl‐sn‐glycero‐3‐phosphocholine (DOPC) and oxidized lipid 1‐palmitoyl‐2‐(5′‐oxo‐valeroyl)‐sn‐glycero‐3‐phosphocholine (POVPC)) were used. B, Effect of the oxidized lipid ratio to the H~2~O~2~ permeability of the liposome. Up to several (2‐4) mol%, the administration of oxidized lipid increased H~2~O~2~ permeability. C, D, Administration of oxidized lipid in HeLa and SAS parental (C) or ρ^0^ (D) cells before H~2~O~2~ treatment. The numbers in parentheses represent the concentration of POVPC (μmol/L). E, F, Effect of the concentration of POVPC on the viability of HeLa and SAS parental (E) or ρ^0^ (F) cells before H~2~O~2~ treatment (25 μmol/L). The results are expressed as the mean ± SEM. \**P *\<* *.05, \*\**P *\<* *.01 using Scheffe\'s *F* test (vs control), ^\#^ *P *\<* *.05, ^\#\#^ *P *\<* *.01 using Scheffe\'s *F* test (vs treatment with H~2~O~2~). C: control, P: treatment with POVPC (12.5 μmol/L), H: treatment with H~2~O~2~ (25 μmol/L for 48 h), P+H: treatment with H~2~O~2~ after treatment with POVPC](CAS-110-2856-g003){#cas14132-fig-0003}

3.4. Gene expression and protein expression of ALOX {#cas14132-sec-0018}
---------------------------------------------------

Gene expression of *ALOX5*,*ALOX12*, and *ALOX15* -- involved in lipid peroxidation of the plasma membrane -- was upregulated in ρ^0^ cells (Figure [4](#cas14132-fig-0004){ref-type="fig"}A: *ALOX5*, 4B: *ALOX12*, and 4C: *ALOX15*). In addition, protein expression of ALOX12 and ALOX15, unlike that of ALOX5, was upregulated in both HeLa and SAS ρ^0^ cells (Figure [4](#cas14132-fig-0004){ref-type="fig"}D and Table [2](#cas14132-tbl-0002){ref-type="table"}). Investigation of spatial distribution showed that the ALOX12 and ALOX15 proteins were distributed in the nucleus and cytoplasm. Conversely, the ALOX5 protein was distributed only in the nucleus (Figure [S1](#cas14132-sup-0001){ref-type="supplementary-material"}). A semiquantitative analysis of immunofluorescence revealed that the relative expression of the ALOX12 and ALOX15 proteins was upregulated in ρ^0^ cells (Figure [5](#cas14132-fig-0005){ref-type="fig"}A, C: ALOX12, Figure [5](#cas14132-fig-0005){ref-type="fig"}B, D: ALOX15).

![Expression of the *ALOX* gene and protein in ρ^0^ cells. A, Expression of the *ALOX5* gene. B, Expression of the *ALOX12* gene. C, Expression of the *ALOX15* gene. The results are expressed as the mean ± SEM. \*\**P *\<* *.01 using Student\'s *t* test. D, Western blotting of ALOX5, ALOX12, and ALOX15. Unlike ALOX5, the expression of ALOX12 and ALOX15 was upregulated in HeLa and SAS ρ^0^ cells](CAS-110-2856-g004){#cas14132-fig-0004}

![Immunofluorescence of ALOX12 and ALOX15. A, B, Spatial distribution of ALOX12 (A) and ALOX15 (B). C, D, Relative expression of ALOX12 (C) and ALOX15 (D). The results are expressed as the mean ± SEM. \**P *\<* *.05, \*\**P *\<* *.01 using Student\'s *t* test](CAS-110-2856-g005){#cas14132-fig-0005}

3.5. Inhibition of ALOX {#cas14132-sec-0019}
-----------------------

Treatment with 10 μmol/L caffeic acid (ALOX‐5 inhibitor) or 10 μmol/L NDGA (universal ALOX inhibitor) was performed before treatment with H~2~O~2~ to investigate the effect of ALOX on the levels of internal H~2~O~2~ or HNE. The results showed that, unlike caffeic acid, NDGA significantly inhibited the levels of internal H~2~O~2~ and lipid peroxidation (Figure [6](#cas14132-fig-0006){ref-type="fig"}).

![Effect of ALOX inhibitor on internal H~2~O~2~ and lipid peroxidation. Treatment with 10 μmol/L caffeic acid (ALOX‐5 inhibitor) or 10 μmol/L nordihydroguaiaretic acid (NDGA) (universal ALOX inhibitor) was performed to investigate their effect on internal H~2~O~2~ and lipid peroxidation. A, Immunofluorescence images of internal H~2~O~2~. B, C, Relative intensity of internal H~2~O~2~ in HeLa (B) and SAS cells (C). D, Immunofluorescence images of 4‐hydroxynonenal (HNE). E, F, Relative intensity of internal H~2~O~2~ in HeLa (E) and SAS (F) cells. Control: no treatment. H~2~O~2~: treatment with 50 μmol/L H~2~O~2~. +CA: treatment with 10 μmol/L caffeic acid before treatment with 50 μmol/L H~2~O~2~. +NDGA: treatment with 10 μmol/L NDGA before treatment with 50 μmol/L H~2~O~2~. The results are expressed as the mean ± SEM.\**P *\<* *.05, \*\**P *\<* *.01 using Scheffe\'s *F* test (vs control), ^\#\#^ *P *\<* *.01 using Scheffe\'s *F* test (vs treatment with H~2~O~2~)](CAS-110-2856-g006){#cas14132-fig-0006}

3.6. Gene and protein expressions of COX {#cas14132-sec-0020}
----------------------------------------

Expression of the *COX1* gene was downregulated in SAS ρ^0^ cells (Figure [7](#cas14132-fig-0007){ref-type="fig"}A). Conversely, expression of the *COX2* gene was significantly upregulated in HeLa and SAS ρ^0^ cells (Figure [7](#cas14132-fig-0007){ref-type="fig"}B). Protein expression of COX1 did not change significantly between parental and ρ^0^ cells, whereas that of COX2 was downregulated in ρ^0^ cells (Figure [7](#cas14132-fig-0007){ref-type="fig"}C and Table [2](#cas14132-tbl-0002){ref-type="table"}). Immunofluorescence of COX revealed that COX1 was mainly localized in the nucleus, whereas COX2 was mainly localized in the cytoplasm (Figure [7](#cas14132-fig-0007){ref-type="fig"}D).

![Gene and protein expression of COX. A, Relative gene expression of *COX1*. B, Relative gene expression of *COX2*. C, Western blotting of COX1 and COX2. D, Spatial distribution of COX1 (green) and COX2 (red) in SAS parent cells. The results are expressed as the mean ± SEM. \**P *\<* *.05, \*\**P *\<* *.01 using Student\'s *t* test](CAS-110-2856-g007){#cas14132-fig-0007}

3.7. Phosphorylation of Akt and protein expressions involved in apoptosis {#cas14132-sec-0021}
-------------------------------------------------------------------------

Phosphorylation of Akt, which inhibits apoptosis and regulates cell proliferation, was investigated using western blotting. This analysis revealed a marked decrease in Akt phosphorylation in ρ^0^ cells (Figure [8](#cas14132-fig-0008){ref-type="fig"} and Table [2](#cas14132-tbl-0002){ref-type="table"}). Expression of Akt downstream proteins was also investigated. Expression of FOXO1, which is downregulated by Akt phosphorylation and inhibited apoptosis, was increased. Moreover, pGSK3β^S9^, which is the inactivated form of GSK3β, was decreased in ρ^0^ cells. Expression of the anti‐apoptotic protein BCL2 was decreased, whereas expression of the apoptosis‐inducing protein Bax was increased in ρ^0^ cells (Figure [8](#cas14132-fig-0008){ref-type="fig"} and Table [2](#cas14132-tbl-0002){ref-type="table"}).

![Downregulation of Akt phosphorylation and promotion of apoptosis signaling in ρ^0^ cells. Western blots of Akt, pAkt^T308^, pAkt^S473^, FOXO1, pGSK3β^S9^, BCL2, Bax, and β‐actin are shown. Downregulation of Akt phosphorylation was observed in both HeLa and SAS ρ^0^ cells. The expression of apoptosis‐promoting proteins (FOXO1 and Bax) was upregulated, whereas that of apoptosis‐inhibiting proteins (pGSK3β^S9^ and BCL2) was downregulated](CAS-110-2856-g008){#cas14132-fig-0008}

4. DISCUSSION {#cas14132-sec-0022}
=============

The present results indicated that the susceptibility of ρ^0^ cells to H~2~O~2~ may be attributed to an increase in the levels of intracellular ROS due to peroxidation of the plasma membrane. ρ^0^ cells from osteosarcomas have previously shown sensitivity to X‐ray irradiation and produced more ROS from mitochondria than their parental cells.[14](#cas14132-bib-0014){ref-type="ref"}, [19](#cas14132-bib-0019){ref-type="ref"} Similarly, lung carcinoma ρ^0^ cells have shown sensitivity to X‐ray irradiation by decreasing the expression of CuZn‐SOD.[19](#cas14132-bib-0019){ref-type="ref"} Conversely, ρ^0^ cells may be resistant to oxidative stress; and ρ^0^ cells from GM701 and BEAS‐2B have shown resistance to irradiation.[19](#cas14132-bib-0019){ref-type="ref"}, [20](#cas14132-bib-0020){ref-type="ref"} Additionally, GM701 ρ^0^ and BEAS‐2B ρ^0^ cells have shown resistance through inhibition of apoptosis and reduction of DNA damage, respectively. However, in these cell lines, intracellular levels of ROS were not determined. Therefore, it remained unknown whether ρ^0^ cells exhibited resistance to ROS, such as H~2~O~2~. Collectively, the increased production of internal ROS via oxidative stress may lead to increased cell death in ρ^0^ cells.

In our study, liposome membrane experiments showed that the content of oxidized lipid in liposomes increased H~2~O~2~ permeability by at least several (2‐4) mol% (Figure [3](#cas14132-fig-0003){ref-type="fig"}A, B). Administration of oxidized lipid to HeLa and SAS parent cells produced a decrease in cell viability following treatment with H~2~O~2~ (Figure [3](#cas14132-fig-0003){ref-type="fig"}C, D). The reduced cell viability induced by 12.5 μmol/L POVPC may reflect the results of the liposome experiments. As shown in Figure [3](#cas14132-fig-0003){ref-type="fig"}B, the highest uptake of H~2~O~2~ was caused at a POVPC concentration of several (2‐4) mol%, and administration of 12.5 μmol/L POVPC (Figure [3](#cas14132-fig-0003){ref-type="fig"}D) induced marked cell damage. In contrast, the administration of oxidized lipid did not affect cell viability following treatment with H~2~O~2~ in ρ^0^ cells, in which lipid peroxidation was enhanced (Figure [3](#cas14132-fig-0003){ref-type="fig"}E, F). From these results, the concentration of the oxidized lipids was thought to influence H~2~O~2~ permeability and viability. However, administration of oxidized lipids to parental cells whose plasma membrane was not highly oxidized, is effective in inducing cell death after treatment with H~2~O~2~. Recently, it was reported that the density of phospholipids in the plasma membrane is involved in the efficiency of membrane permeability (ie, uptake of ions or low‐molecular‐weight substances, such as H~2~O~2~).[29](#cas14132-bib-0029){ref-type="ref"} The results of our liposome experiment are in accordance with those findings reported by a recent study,[29](#cas14132-bib-0029){ref-type="ref"} suggesting that different densities of POVPC influence H~2~O~2~ membrane permeability. Uptake of H~2~O~2~ may be largely related to changes in the plasma membrane itself, rather than the presence of functional proteins on the membrane (ie, aquaporins) that are involved in the permeation of H~2~O~2~ into the cell.[30](#cas14132-bib-0030){ref-type="ref"}, [31](#cas14132-bib-0031){ref-type="ref"}, [32](#cas14132-bib-0032){ref-type="ref"}, [33](#cas14132-bib-0033){ref-type="ref"}

In HeLa and SAS ρ^0^ cells, lipid peroxidation in the plasma membrane was higher than that observed in parental cells. The following three factors may be involved in lipid peroxidation and cell death: (a) downregulation of the antioxidant enzymes; (b) upregulation of the endogenous levels of ROS; and (c) upregulation of intracellular oxidase. It has been reported that catalase activity and expression of the *Mn‐SOD* gene were upregulated in ρ^0^ cells. In addition, expression of the *GPx1* gene was downregulated in SAS ρ^0^ cells, whereas it was upregulated in HeLa ρ^0^ cells.[17](#cas14132-bib-0017){ref-type="ref"} In osteosarcoma, rhabdomyosarcoma, and lung ρ^0^ cells, glutathione peroxidase activity and the expression levels of the *Mn‐SOD* and *CuZn‐SOD* genes were upregulated. However, expression of the CuZn‐SOD protein in osteosarcoma ρ^0^ cells was downregulated.[34](#cas14132-bib-0034){ref-type="ref"} These results suggested that antioxidant enzymes are not the main factors involved in lipid peroxidation in ρ^0^ cells. It has been reported that the levels of superoxide from the mitochondria are decreased in ρ^0^ cells.[35](#cas14132-bib-0035){ref-type="ref"}

Moreover, it has been reported that the administration of HNE leads to increased levels of internal ROS using 2′,7′‐dichlorodihydrofluorescein diacetate in parental cells. However, the levels of internal ROS in ρ^0^ cells did not increase significantly.[36](#cas14132-bib-0036){ref-type="ref"} Our data showed that the levels of HNE and ･OH were increased in ρ^0^ cells (Figures [2](#cas14132-fig-0002){ref-type="fig"} and [S2](#cas14132-sup-0001){ref-type="supplementary-material"}). Currently, the involvement of mitochondria‐derived ROS in lipid peroxidation of the plasma membrane in ρ^0^ cells remains unknown. It has been reported that an increase in ･OH from the mitochondria was detected in osteosarcoma ρ^0^ cells.[14](#cas14132-bib-0014){ref-type="ref"} Additionally, it has been reported that ･OH in cells was involved in the initiation of lipid peroxidation.[37](#cas14132-bib-0037){ref-type="ref"} Moreover, H~2~O~2~ reportedly produced ･OH in the presence of ferrous ion, leading to lipid peroxidation and cell death.[38](#cas14132-bib-0038){ref-type="ref"} These results indicated a positive correlation between the levels of ･OH and lipid peroxidation of the plasma membrane in ρ^0^ cells.

The expression of ALOX12 and ALOX15 (mRNA and protein levels) and *COX2* was upregulated in ρ^0^ cells (Figure [4](#cas14132-fig-0004){ref-type="fig"}, [5](#cas14132-fig-0005){ref-type="fig"}, [6](#cas14132-fig-0006){ref-type="fig"}, [7](#cas14132-fig-0007){ref-type="fig"}). ALOX15 produces 13‐hydroxyoctadecadienoic acid, which is a precursor of HNE from linoleic acid.[39](#cas14132-bib-0039){ref-type="ref"} Inhibition of ALOX 12 and 15, unlike ALOX5, resulted in the downregulation of HNE and H~2~O~2~ permeability in ρ^0^ cells (Figure [6](#cas14132-fig-0006){ref-type="fig"}). Moreover, overexpression of *ALOX15* enhanced erastin and RAS‐selective lethal compound 3‐induced ferroptosis, an iron‐dependent cell death via activation of the HNE.[40](#cas14132-bib-0040){ref-type="ref"} Furthermore, LOX15 reportedly plays a central role in the initiation and execution of ferroptosis.[41](#cas14132-bib-0041){ref-type="ref"} These results suggested that the expression of internal oxidative enzymes is more important than that of antioxidative enzymes for lipid oxidation in ρ^0^ cells. Additionally, ALOX15 plays an important role in the peroxidation of the plasma membrane in ρ^0^ cells. To date, there is no evidence showing that COX2 directly peroxidizes lipids and produces HNE. However, it has been reported that HNE induces the expression of the *COX2* gene, and that this expression is stabilized by the p38 mitogen‐activated protein kinase.[42](#cas14132-bib-0042){ref-type="ref"} In addition, COX2 has been reported to be involved in PI3K/Akt signaling.[43](#cas14132-bib-0043){ref-type="ref"} Recently, it was reported that administration of HNE decreased Akt phosphorylation and induced apoptosis in an osteosarcoma cell line.[44](#cas14132-bib-0044){ref-type="ref"} These findings indicated a strong relationship between lipid peroxidation and intracellular signal pathways (eg, Akt signaling). It has been shown that phosphorylation of Akt was downregulated in HeLa ρ^0^ cells.[45](#cas14132-bib-0045){ref-type="ref"} Our results showed that Akt phosphorylation was downregulated in both types of ρ^0^ cells (Figure [8](#cas14132-fig-0008){ref-type="fig"}). Moreover, an apoptosis‐promoting signal was activated in ρ^0^ cells (Figure [8](#cas14132-fig-0008){ref-type="fig"} and Table [2](#cas14132-tbl-0002){ref-type="table"}). These results indicated that the downregulation of Akt phosphorylation promoted cell death (ie, apoptosis and/or ferroptosis) in ρ^0^ cells via upregulation of *COX2*.

In conclusion, the sensitivity of ρ^0^ cells to treatment with H~2~O~2~ may be due to peroxidation of the plasma membrane, leading to increases in H~2~O~2~ permeability and cell death. Moreover, alterations in the state of the membrane may change the susceptibility of cells to drugs. These findings offer promise for the development of novel anticancer drugs, altering the oxidation state of the plasma membrane. Such drugs may be helpful in overcoming resistance to RT and drug therapy in cells.
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